460 related articles for article (PubMed ID: 21766833)
21. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
23. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
[TBL] [Abstract][Full Text] [Related]
24. Chromium (III) and chromium (VI) as important players in the induction of genotoxicity - current view.
Sawicka E; Jurkowska K; Piwowar A
Ann Agric Environ Med; 2021 Mar; 28(1):1-10. PubMed ID: 33775062
[TBL] [Abstract][Full Text] [Related]
25. Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway.
Wang X; Mandal AK; Saito H; Pulliam JF; Lee EY; Ke ZJ; Lu J; Ding S; Li L; Shelton BJ; Tucker T; Evers BM; Zhang Z; Shi X
Toxicol Appl Pharmacol; 2012 Jul; 262(1):11-21. PubMed ID: 22552367
[TBL] [Abstract][Full Text] [Related]
26. Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.
Mezencev R; Auerbach SS
Toxicol Appl Pharmacol; 2021 Dec; 433():115773. PubMed ID: 34688701
[TBL] [Abstract][Full Text] [Related]
27. Intracellular and extracellular factors influencing Cr(VI) and Cr(III) genotoxicity.
Sobol Z; Schiestl RH
Environ Mol Mutagen; 2012 Mar; 53(2):94-100. PubMed ID: 22020802
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessment.
Thompson CM; Rager JE; Suh M; Ring CL; Proctor DM; Haws LC; Fry RC; Harris MA
Environ Mol Mutagen; 2016 Dec; 57(9):706-716. PubMed ID: 27859739
[TBL] [Abstract][Full Text] [Related]
29. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
30. Hexavalent chromium reduction kinetics in rodent stomach contents.
Proctor DM; Suh M; Aylward LL; Kirman CR; Harris MA; Thompson CM; Gürleyük H; Gerads R; Haws LC; Hays SM
Chemosphere; 2012 Oct; 89(5):487-93. PubMed ID: 22682893
[TBL] [Abstract][Full Text] [Related]
31. Toxicological Antagonism among Welding Fume Metals: Inactivation of Soluble Cr(VI) by Iron.
Krawic C; Zhitkovich A
Chem Res Toxicol; 2018 Nov; 31(11):1172-1184. PubMed ID: 30362728
[TBL] [Abstract][Full Text] [Related]
32. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium.
Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM
Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460
[TBL] [Abstract][Full Text] [Related]
33. A review of mammalian
Thompson CM; Aardema MJ; Heintz MM; MacGregor JT; Young RR
Crit Rev Toxicol; 2021 Nov; 51(10):820-849. PubMed ID: 35060824
[TBL] [Abstract][Full Text] [Related]
34. Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity.
De Flora S; Camoirano A; Micale RT; La Maestra S; Savarino V; Zentilin P; Marabotto E; Suh M; Proctor DM
Toxicol Appl Pharmacol; 2016 Sep; 306():113-9. PubMed ID: 27404458
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action.
Thompson CM; Proctor DM; Suh M; Haws LC; Hébert CD; Mann JF; Shertzer HG; Hixon JG; Harris MA
Toxicol Sci; 2012 Jan; 125(1):79-90. PubMed ID: 22011396
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
[TBL] [Abstract][Full Text] [Related]
37. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.
Thompson CM; Kirman CR; Proctor DM; Haws LC; Suh M; Hays SM; Hixon JG; Harris MA
J Appl Toxicol; 2014 May; 34(5):525-36. PubMed ID: 23943231
[TBL] [Abstract][Full Text] [Related]
38. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity.
Pattison DI; Davies MJ; Levina A; Dixon NE; Lay PA
Chem Res Toxicol; 2001 May; 14(5):500-10. PubMed ID: 11368547
[TBL] [Abstract][Full Text] [Related]
39. Waterborne and dietary hexavalent chromium exposure causes DNA-protein crosslink (DPX) formation in erythrocytes of largemouth bass (Micropterus salmoides).
Kuykendall JR; Miller KL; Mellinger KN; Cain AV
Aquat Toxicol; 2006 Jun; 78(1):27-31. PubMed ID: 16672167
[TBL] [Abstract][Full Text] [Related]
40. Review of the evidence regarding the carcinogenicity of hexavalent chromium in drinking water.
Sedman RM; Beaumont J; McDonald TA; Reynolds S; Krowech G; Howd R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006 Apr; 24(1):155-82. PubMed ID: 16690539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
